MALVERN, Pa., April 02, 2024 Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today provided a summary of corporate updates.
Syneos Health leaves state jobs deal, months after Morrisville company goes private yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of James Wentworth, PhD, MBA, as Chief Business Officer (CBO) and member of the executive management team, effective immediately. Dr. Wentworth will be responsible for developing, leading, and implementing Transgene’s business, corporate development and partnering strategi
BERWYN, Pa., Dec. 01, 2023 Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease .